What is CAR-T Cell Immunotherapy? - Metastatic Breast Cancer Trial Talk

From the Experts

CAR-T is a personalized immunotherapy made from a patient’s white blood cells. The blood cells are removed from the patient and then modified with chimeric antigen receptors (CARs) so they can attack specific proteins. The cells are then infused back into the patient in the hospital.

CAR-T therapy has been approved for treating certain types of blood cancers. Clinical trials are now underway to see if it will be effective in treating metastatic breast cancer. You can find the breast cancer CAR-T trials now enrolling patients below.

CAR-T Therapy: An Overview

Current CAR-T Trials:

More immunotherapy articles on Metastatictrialtalk.org

Last Modified on February 24, 2021



for past articles or specific information.